🌶️Hot Movers: Strategic restructurings and new orders ignite pre-market activity!

In partnership with

& B&L Ventures

Good day, 360!

Here are some of our top movers today🔥. And please join us in Market Masters - where Jeff Bishop welcomes his perhaps FIRST Risk Management Coach today @ 1pm EST (ALL LEVELS WELCOME). Be the best prepared (and most educated) trader on the Street!

FOCUS LIST🔎

MSPR - Up over 130% in the pre-market after announcing strategic term sheet providing prospective liquidity and restructuring of existing agreements to remove corporate guaranteed debt by over $1.2 billion as well as new agreements aimed at driving future growth

BON - Up over 70% in pre after announcing  Apple Polyphenol commercial order signed

VERO - Up over 35% in pre after announcing closing of $1.1 million registered direct offering of common stock priced at-the-market under Nasdaq rules

HOTLIST🔥

MSPR - Up over 130% in the pre-market after announcing strategic term sheet providing prospective liquidity and restructuring of existing agreements to remove corporate guaranteed debt by over $1.2 billion as well as new agreements aimed at driving future growth

MSP Recovery Inc. (MSPR) doing business as LifeWallet, operates as a healthcare recovery and data analytics company in the United States and Puerto Rico.

In the after-hours yesterday, the company announced that it entered into a strategic term sheet agreeing to several restructuring transactions with Hazel Partners Holdings, LLC, Virage Capital Management , and their respective affiliates. 

These initiatives are designed to reduce costs of the Company through a New Servicer entity, deleverage the Company by converting certain debt of significant creditors into equity and release $1.2 billion of debt guaranteed by the Company, provide access to $9.75 million of bridge funding to the Company (of which $6.5 million remains available through July 2025) and up to $25 million working capital for New Servicer, and to focus the Company’s operations, through the New Servicer, on the core business model of pursuing recoveries under the MSP Laws so that it can achieve its long-term recovery goals. 

Shares of MSPR traded up over 130% in the pre-market in reaction to the news.

The $2.85 area acted as support in the pre-market and will be an important level to watch.

Above it, targets to the upside are $3.30, $3.55, $4 and then the pre-market high at $4.11. Beyond that, $5, $6 and $7 come into play.

Below $2.85, targets to the downside are $2.50, $2.20, $2, $1.70 and $1.60.

BON - Up over 70% in the pre-market after announcing  Apple Polyphenol commercial order signed

Bon Natural Life Limited (BON) is a leading bio-ingredient solution provider in the natural, health and personal care industry.

In the pre-market this morning, the company announced a groundbreaking 24-month supply agreement worth $12M with Shanghai Yunsheng, China's premier functional ingredients distributor, to co-develop next-generation apple polyphenol-infused health solutions. 

The partnership leverages BON's patented extraction technology to deliver science-backed formulations combining antioxidant-rich apple polyphenols with plant-based proteins, proven to support weight management and metabolic health.

Early market validation proves compelling-comparable apple polyphenol blends have achieved blockbuster status since launch, selling over half a million units monthly and generating $40M in recurring revenue.

Shares of BON traded up over 70% in the pre-market in reaction to the news.

The $0.095 area acted as resistance in the pre-market and now becomes a potential level of support.

Above it, targets to the upside are $0.10, $0.11 and then the pre-market high at $0.1205. Beyond that, $0.15 and $0.18 come into play.

Below $0.095, targets to the downside are $0.09, $0.085, $0.0742, $0.07 and a gap fill at $0.0607.

VERO - Up over 35% in pre after announcing closing of $1.1 million registered direct offering of common stock priced at-the-market under Nasdaq rules

Venus Concept Inc. (VERO) is a medical technology company that develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally.

In the after-hours yesterday, the company announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase and sale of 328,573 shares of common stock at a purchase price of $3.50 per share.

H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.

The gross proceeds to the Company from the offering were approximately $1.1 million, before deducting placement agent fees and other offering expenses payable by the Company. The Company intends to use the net proceeds from the offering for general corporate purposes.

Shares of VERO traded up over 35% in the pre-market in reaction to the news.

The $5 area acted as support in the pre-market and will be an important level to watch.

Above it, targets to the upside are $5.50, $6, $6.50, $7 and then the pre-market high at $7.50. Beyond that, $8, $9.50 and $11 come into play.

Below $5, targets to the downside are $4.50 and then a gap fill at $4.06.

MARKET NEWS 📰

Don't miss out on our MOBILE ALERTS!  Some of these alerts have rocketed 🚀past the MOON 🌝.  Text “RAGE” to 1-(888) 487-1534 📲.

*Disclosure: By texting “RAGE” to 1-(888) 487-1534, you agree to receive promotional messages sent via an autodialer. You also agree to the terms of service and privacy policy. This agreement isn’t a condition of any purchase. Message frequency varies. Message and data rates may apply. Reply STOP to opt out; HELP for more information.